This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Rite Aid Balance Sheet Health

Financial Health criteria checks 0/6

Rite Aid has a total shareholder equity of $-2.0B and total debt of $3.8B, which brings its debt-to-equity ratio to -191.6%. Its total assets and total liabilities are $7.1B and $9.1B respectively.

Key information

-191.6%

Debt to equity ratio

US$3.77b

Debt

Interest coverage ration/a
CashUS$97.12m
Equity-US$1.97b
Total liabilitiesUS$9.09b
Total assetsUS$7.13b

Recent financial health updates

Recent updates

Rite Aid Shareholders Are Wiped Out Under A Chapter 11 Bankruptcy Plan

Oct 16

Rite Aid May Be Forced Into Ch.11 Bankruptcy To Resolve Opioid Liabilities

Jul 10

Rite Aid Q1 Earnings Preview: Bears Remain In Control

Jun 27

Rite Aid names interim CEO as Heyward Donigan departs

Jan 09

Rite Aid Q3 2023 Earnings Preview

Dec 20

Rite Aid spikes 20% on above average volume

Nov 15

Rite Aid partners with Google Cloud on pharmacy insights, customer engagement

Oct 11

Financial Position Analysis

Short Term Liabilities: RADC.Q has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: RADC.Q has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: RADC.Q has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: RADC.Q's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if RADC.Q has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if RADC.Q has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/09/03 05:42
End of Day Share Price 2024/09/03 00:00
Earnings2023/09/02
Annual Earnings2023/03/04

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rite Aid Corporation is covered by 19 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Steven ValiquetteBofA Global Research
William FrohnhoeferBTIG
Arun SundaramCFRA Equity Research